Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Knowledge, Perceptions, and Perspectives of Medical Students Regarding the Use of Antibiotics and Antibiotic Resistance: A Qualitative Research in Galicia, Spain.
Antibiotics (Basel). 2023 Mar 11;12(3):558. doi: 10.3390/antibiotics12030558.
Antibiotics (Basel). 2023.
PMID: 36978424
Free PMC article.
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats.
Aragón-Herrera A, Moraña-Fernández S, Otero-Santiago M, Anido-Varela L, Campos-Toimil M, García-Seara J, Román A, Seijas J, García-Caballero L, Rodríguez J, Tarazón E, Roselló-Lletí E, Portolés M, Lage R, Gualillo O, González-Juanatey JR, Feijóo-Bandín S, Lago F.
Aragón-Herrera A, et al. Among authors: otero santiago m.
Biomed Pharmacother. 2023 May;161:114535. doi: 10.1016/j.biopha.2023.114535. Epub 2023 Mar 15.
Biomed Pharmacother. 2023.
PMID: 36931025
Free article.
Item in Clipboard
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.
Feijóo-Bandín S, Aragón-Herrera A, Otero-Santiago M, Anido-Varela L, Moraña-Fernández S, Tarazón E, Roselló-Lletí E, Portolés M, Gualillo O, González-Juanatey JR, Lago F.
Feijóo-Bandín S, et al. Among authors: otero santiago m.
Int J Mol Sci. 2022 May 18;23(10):5634. doi: 10.3390/ijms23105634.
Int J Mol Sci. 2022.
PMID: 35628443
Free PMC article.
Review.
Item in Clipboard
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile.
Aragón-Herrera A, Otero-Santiago M, Anido-Varela L, Moraña-Fernández S, Campos-Toimil M, García-Caballero T, Barral L, Tarazón E, Roselló-Lletí E, Portolés M, Gualillo O, Moscoso I, Lage R, González-Juanatey JR, Feijóo-Bandín S, Lago F.
Aragón-Herrera A, et al. Among authors: otero santiago m.
Front Pharmacol. 2022 Feb 2;13:827033. doi: 10.3389/fphar.2022.827033. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35185578
Free PMC article.
Item in Clipboard
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats.
Aragón-Herrera A, Feijóo-Bandín S, Otero Santiago M, Barral L, Campos-Toimil M, Gil-Longo J, Costa Pereira TM, García-Caballero T, Rodríguez-Segade S, Rodríguez J, Tarazón E, Roselló-Lletí E, Portolés M, Gualillo O, González-Juanatey JR, Lago F.
Aragón-Herrera A, et al. Among authors: otero santiago m.
Biochem Pharmacol. 2019 Dec;170:113677. doi: 10.1016/j.bcp.2019.113677. Epub 2019 Oct 21.
Biochem Pharmacol. 2019.
PMID: 31647926
Item in Clipboard
Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.
Ferreiro-Iglesias R, Barreiro-de Acosta M, Otero Santiago M, Lorenzo Gonzalez A, Alonso de la Peña C, Benitez Estevez AJ, Dominguez-Muñoz JE.
Ferreiro-Iglesias R, et al. Among authors: otero santiago m.
J Clin Gastroenterol. 2016 Feb;50(2):147-51. doi: 10.1097/MCG.0000000000000312.
J Clin Gastroenterol. 2016.
PMID: 25811118
Item in Clipboard
Epidemiology of tuberculosis in Galicia, Spain, 16 years after the launch of the Galician tuberculosis programme.
Cruz-Ferro E, Ursúa-Díaz MI, Taboada-Rodríguez JA, Hervada-Vidal X, Anibarro L, Túñez V; Galician Tuberculosis Prevention and Control Programme Working Group.
Cruz-Ferro E, et al.
Int J Tuberc Lung Dis. 2014 Feb;18(2):134-40. doi: 10.5588/ijtld.13.0419.
Int J Tuberc Lung Dis. 2014.
PMID: 24429303
Item in Clipboard
Cite
Cite